Osler, Hoskin & Harcourt LLP advised Inversago Pharma on the matter. On August 10, 2023, Inversago Pharma announced its business combination with Nova Nordisk for US$1.075...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here